These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2387380

  • 1. [The metabolism of bonnecor].
    Rodionov AP, Antonova AV, Krasnykh LM, Ignatova NA, Klemm V, Morgenroth U.
    Farmakol Toksikol; 1990; 53(3):44-6. PubMed ID: 2387380
    [Abstract] [Full Text] [Related]

  • 2. [The relationship between the physicochemical and pharmacokinetic parameters and the anti-arrhythmia activity of bonnecor and its metabolites].
    Rodionov AP, Zolotov NN, Lyskovtsev VV, Zalilov KIu, Poppe H.
    Farmakol Toksikol; 1990; 53(3):50-1. PubMed ID: 2387383
    [Abstract] [Full Text] [Related]

  • 3. [The pharmacokinetics and metabolism of bonnecor in rats].
    Klemm V, Morgenroth U, Starke F, Zeriatke W, Ioram U.
    Farmakol Toksikol; 1990; 53(3):43-4. PubMed ID: 2387379
    [Abstract] [Full Text] [Related]

  • 4. [A comparative study of the pharmacokinetics and pharmacodynamics of bonnecor].
    Rodionov AP, Lyskovtsev VV, Ignatova NA, Tolmacheva EA, Grigor'eva EK, Belinskiaia GF, Sheĭnberg BV.
    Farmakol Toksikol; 1990; 53(3):40-3. PubMed ID: 1696909
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetics and metabolism of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the rat].
    Klemm W, Morgenroth U, Joram U, Rodionov AP.
    Pharmazie; 1985 Dec; 40(12):864-7. PubMed ID: 3841605
    [Abstract] [Full Text] [Related]

  • 6. [Pharmaceutical characterization and spectroscopy of Bonnecor (AWD 19-166, GS 015)].
    Mayer W, Usbeck H, Rodionov AP.
    Pharmazie; 1985 Dec; 40(12):832-5. PubMed ID: 3841596
    [Abstract] [Full Text] [Related]

  • 7. Relation between renal and hepatic excretion of drugs: XIII. Pharmacokinetics of new antiarrhythmic drug Bonnecor in rats with normal and impaired excretory functions.
    Fleck C, Richter S, Tischendorf G, Klemm W, Bräunlich H.
    Exp Pathol; 1989 Dec; 36(3):165-75. PubMed ID: 2503392
    [Abstract] [Full Text] [Related]

  • 8. [Possibilities for increasing the elimination rate of Bonnecor].
    Fleck C, Schilder L, Schulze U, Pfister M, Stein G, Landmann H, Schwachula G, Bräunlich H.
    Z Gesamte Inn Med; 1990 Oct 15; 45(20):604-9. PubMed ID: 2129177
    [Abstract] [Full Text] [Related]

  • 9. [The pharmacodynamics and pharmacokinetics of bonnecor in patients with different disorders of the heart rhythm].
    Lozinskiĭ LG, Zamotaev IP, Zeltyn'-Abramov EM, Orlov VA, Beloborodov VL, Kosilova EE, Zalesskaia MA, Tiukavkina NA.
    Farmakol Toksikol; 1990 Oct 15; 53(3):61-3. PubMed ID: 2387386
    [Abstract] [Full Text] [Related]

  • 10. The metabolism of mianserin in women, rabbits, and rats: identification of the major urinary metabolites.
    de Jongh GD, van den Wildenberg HM, Nieuwenhuyse H, van der Veen F.
    Drug Metab Dispos; 1981 Oct 15; 9(1):48-53. PubMed ID: 6111431
    [Abstract] [Full Text] [Related]

  • 11. Relation between renal and hepatic excretion of drugs: XV. Organ distribution and transport of the new antiarrhythmic drug Bonnecor in kidney and liver of rats.
    Fleck C, Bräunlich H.
    Exp Pathol; 1991 Oct 15; 42(3):137-44. PubMed ID: 1915757
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacological research on bonnecor and its metabolites].
    Poppe H, Heer S, Barch R.
    Farmakol Toksikol; 1990 Oct 15; 53(3):46-8. PubMed ID: 2387381
    [Abstract] [Full Text] [Related]

  • 13. [New derivatives of 10,11-dihydro-5H-dibenz[b,f]azepine with antiarrhythmic action].
    Wunderlich H, Stark A, Carstens E, Lohmann D, Grizenko AN, Skoldinov AP.
    Pharmazie; 1985 Dec 15; 40(12):827-30. PubMed ID: 4095140
    [Abstract] [Full Text] [Related]

  • 14. Biotransformation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent, in rat liver microsomes.
    Stefek M, Benes L, Jergelová M, Scasnár V, Turi-Nagy L, Kocis P.
    Xenobiotica; 1987 Sep 15; 17(9):1067-73. PubMed ID: 3687063
    [Abstract] [Full Text] [Related]

  • 15. [The anti-arrhythmia properties of bonnecor metabolites].
    Grigor'eva EK, Poppe H, Tolmacheva EA, Krasnykh LM.
    Farmakol Toksikol; 1990 Sep 15; 53(3):48-50. PubMed ID: 2387382
    [Abstract] [Full Text] [Related]

  • 16. In vivo studied on the metabolism of dibenzo [c,f]-[1,2] diazepine.
    Frigerio A, Negrini P, Cappellini L, Rotilio D, De Pascale A, Rossi E.
    Eur J Drug Metab Pharmacokinet; 1979 Sep 15; 4(2):67-74. PubMed ID: 488134
    [Abstract] [Full Text] [Related]

  • 17. Determination of quinupramin in plasma and urine by capillary column gas chromatography-mass spectrometry.
    Bouquet S, Girault J, Ly UH, Saux MC, Lefebvre MA, Fourtillan JB.
    J Chromatogr; 1986 Dec 19; 383(2):393-9. PubMed ID: 3558568
    [No Abstract] [Full Text] [Related]

  • 18. Carbamazepine-10,11-epoxide metabolites in rat urine.
    Belvedere G, Pantarotto C, Frigerio A.
    Res Commun Chem Pathol Pharmacol; 1975 Jun 19; 11(2):221-32. PubMed ID: 1153869
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Method for the detection of imipraminic antidepressants in urine by gas chromatography and thin layer chromatography].
    Viala A, Gola C, Cano JP, Gouezo F.
    Ann Pharm Fr; 1972 Jun 19; 30(6):445-57. PubMed ID: 4638740
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.